Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis.

MLA

Junjie Ao, et al. “Dual Effects of Targeting Neuropilin-1 in Lenvatinib-Resistant Hepatocellular Carcinoma: Inhibition of Tumor Growth and Angiogenesis.” American Journal of Physiology: Cell Physiology, vol. 327, no. 4, Oct. 2024, pp. C1150–61. EBSCOhost, https://doi.org/10.1152/ajpcell.00511.2024.

APA

Junjie Ao, Na Qiang, Hiroaki Kanzaki, Masato Nakamura, Kakiuchi, R., Jiaqi Zhang, Ryuta Kojima, Keisuke Koroki, Masanori Inoue, Naoya Kanogawa, Ryo Nakagawa, Takayuki Kondo, Sadahisa Ogasawara, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, & Naoya Kato. (2024). Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis. American Journal of Physiology: Cell Physiology, 327(4), C1150–C1161. https://doi.org/10.1152/ajpcell.00511.2024

Chicago

Junjie Ao, Na Qiang, Hiroaki Kanzaki, Masato Nakamura, Risa Kakiuchi, Jiaqi Zhang, Ryuta Kojima, et al. 2024. “Dual Effects of Targeting Neuropilin-1 in Lenvatinib-Resistant Hepatocellular Carcinoma: Inhibition of Tumor Growth and Angiogenesis.” American Journal of Physiology: Cell Physiology 327 (4): C1150–61. doi:10.1152/ajpcell.00511.2024.